In 2010, Zhou and colleagues found that TXNIP induced inflammasome activation, resulting in the production of interleukin (IL)-1β, a key cytokine involved in T1D, and that TXNIP downregulation could have anti-inflammatory effects (Zhou et al., 2010). This evidence concerns the gene TXNIP and type 1 diabetes mellitus.